Local application of Shukti bhasma to stop haemorrhage
Not yet recruiting
- Conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Ayurveda Condition: RAKTASRAVAH,
- Registration Number
- CTRI/2025/05/087256
- Lead Sponsor
- DMM Ayurved Mahavidyalaya,Yavatmal
- Brief Summary
This study is randomized trail comparing the efficacy and safety of shukti bhsasma and haemocoagulase solution for haemostasis of capillary and venous haemorrhage in 35 patients of each group that will be conducted in India.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- 1.The patients have any external capillary or venous haemorrhage from wounds resulting due to surgery or trauma on the whole body 2.Patients with ongoing antiplatelet or anticoagulant therapy like aspirin, clopidogrel, warfarin and heparin will also be included.
- 3.Patients irrespective of gender, religion, marital status and socioeconomic class will be selected 4.Patients who will give their consent to participate.
Exclusion Criteria
- The patients pre-diagnosed with bleeding disorders such as Haemophilia or Von Willebrand disease, sickle cell disease, anaemia (Hb less than 8gm), thrombocytopenia, who require BT, who have just received BT.
- who need emergency surgical care and shock will be excluded.
- Patients with arterial bleeding or associated arterial bleeding.
- Patients with other systemic diseases such as AIDS, HBsAg, TB, Uncon trolled Diabetes, Uncontrolled Hypertension, Malignancy, Leprosy and STDs. 4.
- Dagdha Vrana.
- Ulcers with no bleeding.
- Patients with wounds due to any animal or insect bite.
- Pregnant and lactating mother.
- Patients with addictions specifically alcohol, tobacco & smoking.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clotting time will be noted after the dusting of Shukti Bhasma a 2mm thick every minute for the first 10 min then | every 2 min for the next 10 min & then every 5 min till 30 min after 1hr, 6hrs, | 24hrs, 48hrs. After 48hrs if there is no bleeding follow-up will be taken after 1 | week. layer over the bleeding site. every minute for the first 10 min then | every 2 min for the next 10 min & then every 5 min till 30 min after 1hr, 6hrs, | 24hrs, 48hrs. After 48hrs if there is no bleeding follow-up will be taken after 1 | week.
- Secondary Outcome Measures
Name Time Method Apart from haemostasis, other effects like discoloura tion, burning, tingling and warmth at the site of bleeding will be assessed.
Trial Locations
- Locations (1)
Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal
🇮🇳Yavatmal, MAHARASHTRA, India
Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal🇮🇳Yavatmal, MAHARASHTRA, IndiaDr Bhushan Baliram KasbePrincipal investigator9158166627princebhushan358@gmail.com